Skip to content
Menu

Wells Fargo Maintains Overweight on CVS Health, Lowers Price Target to $112

Benzinga Newsdesk 4 days ago

Analyst RatingsNewsPrice TargetHot

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Wells Fargo analyst Stephen Baxter maintains CVS Health (NYSE:CVS) with a Overweight and lowers the price target from $123 to $112.

Wells Fargo analyst Stephen Baxter maintains CVS Health (NYSE:CVS) with a Overweight and lowers the price target from $123 to $112.

Read at benzinga.com